Welcome to ’tissue therapeutics’: Dave Lennon’s $110M new venture will implant ‘happy cells’ that ‘survive and thrive’
Eleos Health raises $20 million to generate insights from mental health clinician-patient conversations
Nectin Therapeutics Announces $5.4 Million Investment from Cancer Focus Fund to Support Phase 1 Study of First-in-Class Anti-PVR Targeted Immunotherapy
Adicet unveils early responses for off-the-shelf drug leveraging rare T cells. Will durability hold up?